Zollinger-Ellison syndrome (ZES) is a rare disorder that
causes tumors in the pancreas and duodenum and ulcers in
the stomach and duodenum. The pancreas is a gland located
behind the stomach. It produces enzymes that break down
fat, protein, and carbohydrates from food, and hormones
like insulin that break down sugar. The duodenum is the
first part of the small intestine.
The tumors secrete a hormone called gastrin that causes
the stomach to produce too much acid, which in turn causes
stomach and duodenal ulcers (peptic ulcers). The ulcers
caused by ZES are less responsive to treatment than ordinary
peptic ulcers. What causes people with ZES to develop tumors
is unknown, but approximately 25 percent of ZES cases are
associated with a genetic disorder called multiple endocrine
neoplasia type 1, which is associated with additional disorders.
The symptoms of ZES include signs of peptic ulcers: gnawing,
burning pain in the abdomen; diarrhea; nausea; vomiting;
fatigue; weakness; weight loss; and bleeding. Physicians
diagnose ZES through blood tests to measure levels of gastrin
and gastric acid secretion. They may check for ulcers by
doing an endoscopy, which involves looking at the lining
of the stomach and duodenum through a lighted tube.
The primary treatment for ZES is medication to reduce
the production of stomach acid. Proton pump inhibitors
that suppress acid production and promote healing are the
first line of treatment and include lansoprazole, omeprazole,
pantoprazole, and rabeprazole. H-2 blockers such as cimetidine,
famotidine, and ranitidine may also be used, but are less
effective in reducing stomach acid. Surgery to treat peptic
ulcers or to remove tumors in the pancreas or duodenum
are other treatment options. People who have been treated
for ZES should be monitored in case the ulcers or tumors
recur.
To read the rest of this article and related
materials from The National Digestive Diseases Information
Clearinghouse, please click here: http://digestive.niddk.nih.gov/ddiseases/pubs/zollinger/index.htm